Global Controlled Release Drug Market Report 2017

Publisher Name :
Date: 09-Nov-2017
No. of pages: 116
Inquire Before Buying

In this report, the global Controlled Release Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Controlled Release Drug for these regions, from 2012 to 2022 (forecast), covering

- United States

- China

- Europe

- Japan

- Southeast Asia

- India

Global Controlled Release Drug market competition by top manufacturers/players, with Controlled Release Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

- Allergan

- BioAlliance Pharma

- Collegium Pharmaceutical

- Controlled Therapeutics

- Cosmo Pharmaceuticals

- Egalet

- Encore Therapeutics

- Flamel Technologies

- GlaxoSmithKline

- iCeutica

- Novartis

- Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Pills

- Capsules

- Injectable Drug Carriers

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Respiratory disease

- Digestive Disease

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Controlled Release Drug Market Report 2017

Table of Contents
Global Controlled Release Drug Sales Market Report 2017
1 Controlled Release Drug Market Overview
1.1 Product Overview and Scope of Controlled Release Drug
1.2 Classification of Controlled Release Drug by Product Category
1.2.1 Global Controlled Release Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Controlled Release Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Pills
1.2.4 Capsules
1.2.5 Injectable Drug Carriers
1.2.6 Others
1.3 Global Controlled Release Drug Market by Application/End Users
1.3.1 Global Controlled Release Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Respiratory disease
1.3.3 Digestive Disease
1.3.4 Others
1.4 Global Controlled Release Drug Market by Region
1.4.1 Global Controlled Release Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Controlled Release Drug Status and Prospect (2012-2022)
1.4.3 China Controlled Release Drug Status and Prospect (2012-2022)
1.4.4 Europe Controlled Release Drug Status and Prospect (2012-2022)
1.4.5 Japan Controlled Release Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia Controlled Release Drug Status and Prospect (2012-2022)
1.4.7 India Controlled Release Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Controlled Release Drug (2012-2022)
1.5.1 Global Controlled Release Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Controlled Release Drug Revenue and Growth Rate (2012-2022)
2 Global Controlled Release Drug Competition by Players/Suppliers, Type and Application
2.1 Global Controlled Release Drug Market Competition by Players/Suppliers
2.1.1 Global Controlled Release Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Controlled Release Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Controlled Release Drug (Volume and Value) by Type
2.2.1 Global Controlled Release Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Controlled Release Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Controlled Release Drug (Volume and Value) by Region
2.3.1 Global Controlled Release Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global Controlled Release Drug Revenue and Market Share by Region (2012-2017)
2.4 Global Controlled Release Drug (Volume) by Application
3 United States Controlled Release Drug (Volume, Value and Sales Price)
3.1 United States Controlled Release Drug Sales and Value (2012-2017)
3.1.1 United States Controlled Release Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Controlled Release Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Controlled Release Drug Sales Price Trend (2012-2017)
3.2 United States Controlled Release Drug Sales Volume and Market Share by Players
3.3 United States Controlled Release Drug Sales Volume and Market Share by Type
3.4 United States Controlled Release Drug Sales Volume and Market Share by Application
4 China Controlled Release Drug (Volume, Value and Sales Price)
4.1 China Controlled Release Drug Sales and Value (2012-2017)
4.1.1 China Controlled Release Drug Sales and Growth Rate (2012-2017)
4.1.2 China Controlled Release Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Controlled Release Drug Sales Price Trend (2012-2017)
4.2 China Controlled Release Drug Sales Volume and Market Share by Players
4.3 China Controlled Release Drug Sales Volume and Market Share by Type
4.4 China Controlled Release Drug Sales Volume and Market Share by Application
5 Europe Controlled Release Drug (Volume, Value and Sales Price)
5.1 Europe Controlled Release Drug Sales and Value (2012-2017)
5.1.1 Europe Controlled Release Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Controlled Release Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Controlled Release Drug Sales Price Trend (2012-2017)
5.2 Europe Controlled Release Drug Sales Volume and Market Share by Players
5.3 Europe Controlled Release Drug Sales Volume and Market Share by Type
5.4 Europe Controlled Release Drug Sales Volume and Market Share by Application
6 Japan Controlled Release Drug (Volume, Value and Sales Price)
6.1 Japan Controlled Release Drug Sales and Value (2012-2017)
6.1.1 Japan Controlled Release Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Controlled Release Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Controlled Release Drug Sales Price Trend (2012-2017)
6.2 Japan Controlled Release Drug Sales Volume and Market Share by Players
6.3 Japan Controlled Release Drug Sales Volume and Market Share by Type
6.4 Japan Controlled Release Drug Sales Volume and Market Share by Application
7 Southeast Asia Controlled Release Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Controlled Release Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Controlled Release Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Controlled Release Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Controlled Release Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Controlled Release Drug Sales Volume and Market Share by Players
7.3 Southeast Asia Controlled Release Drug Sales Volume and Market Share by Type
7.4 Southeast Asia Controlled Release Drug Sales Volume and Market Share by Application
8 India Controlled Release Drug (Volume, Value and Sales Price)
8.1 India Controlled Release Drug Sales and Value (2012-2017)
8.1.1 India Controlled Release Drug Sales and Growth Rate (2012-2017)
8.1.2 India Controlled Release Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Controlled Release Drug Sales Price Trend (2012-2017)
8.2 India Controlled Release Drug Sales Volume and Market Share by Players
8.3 India Controlled Release Drug Sales Volume and Market Share by Type
8.4 India Controlled Release Drug Sales Volume and Market Share by Application
9 Global Controlled Release Drug Players/Suppliers Profiles and Sales Data
9.1 Allergan
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Controlled Release Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Allergan Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 BioAlliance Pharma
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Controlled Release Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 BioAlliance Pharma Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Collegium Pharmaceutical
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Controlled Release Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Collegium Pharmaceutical Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Controlled Therapeutics
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Controlled Release Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Controlled Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Cosmo Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Controlled Release Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Cosmo Pharmaceuticals Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Egalet
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Controlled Release Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Egalet Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Encore Therapeutics
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Controlled Release Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Encore Therapeutics Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Flamel Technologies
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Controlled Release Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Flamel Technologies Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 GlaxoSmithKline
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Controlled Release Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 GlaxoSmithKline Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 iCeutica
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Controlled Release Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 iCeutica Controlled Release Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Novartis
9.12 Pfizer
10 Controlled Release Drug Maufacturing Cost Analysis
10.1 Controlled Release Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Controlled Release Drug
10.3 Manufacturing Process Analysis of Controlled Release Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Controlled Release Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Controlled Release Drug Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Controlled Release Drug Market Forecast (2017-2022)
14.1 Global Controlled Release Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Controlled Release Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Controlled Release Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Controlled Release Drug Price and Trend Forecast (2017-2022)
14.2 Global Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Controlled Release Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Controlled Release Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Controlled Release Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Controlled Release Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Controlled Release Drug Sales Forecast by Type (2017-2022)
14.3.2 Global Controlled Release Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global Controlled Release Drug Price Forecast by Type (2017-2022)
14.4 Global Controlled Release Drug Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Controlled Release Drug
Figure Global Controlled Release Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Controlled Release Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Pills Product Picture
Figure Capsules Product Picture
Figure Injectable Drug Carriers Product Picture
Figure Others Product Picture
Figure Global Controlled Release Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Controlled Release Drug by Application in 2016
Figure Respiratory disease Examples
Table Key Downstream Customer in Respiratory disease
Figure Digestive Disease Examples
Table Key Downstream Customer in Digestive Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Controlled Release Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Controlled Release Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Controlled Release Drug Sales Volume (K Pcs) (2012-2017)
Table Global Controlled Release Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Controlled Release Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Controlled Release Drug Sales Share by Players/Suppliers
Figure 2017 Controlled Release Drug Sales Share by Players/Suppliers
Figure Global Controlled Release Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Controlled Release Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Controlled Release Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Controlled Release Drug Revenue Share by Players
Table 2017 Global Controlled Release Drug Revenue Share by Players
Table Global Controlled Release Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Controlled Release Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Controlled Release Drug by Type (2012-2017)
Figure Global Controlled Release Drug Sales Growth Rate by Type (2012-2017)
Table Global Controlled Release Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Controlled Release Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Controlled Release Drug by Type (2012-2017)
Figure Global Controlled Release Drug Revenue Growth Rate by Type (2012-2017)
Table Global Controlled Release Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Controlled Release Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Controlled Release Drug by Region (2012-2017)
Figure Global Controlled Release Drug Sales Growth Rate by Region in 2016
Table Global Controlled Release Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Controlled Release Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Controlled Release Drug by Region (2012-2017)
Figure Global Controlled Release Drug Revenue Growth Rate by Region in 2016
Table Global Controlled Release Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Controlled Release Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Controlled Release Drug by Region (2012-2017)
Figure Global Controlled Release Drug Revenue Market Share by Region in 2016
Table Global Controlled Release Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Controlled Release Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Controlled Release Drug by Application (2012-2017)
Figure Global Controlled Release Drug Sales Market Share by Application (2012-2017)
Figure United States Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure United States Controlled Release Drug Sales Volume Market Share by Players in 2016
Table United States Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure United States Controlled Release Drug Sales Volume Market Share by Type in 2016
Table United States Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure United States Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure China Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure China Controlled Release Drug Sales Volume Market Share by Players in 2016
Table China Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure China Controlled Release Drug Sales Volume Market Share by Type in 2016
Table China Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure China Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Europe Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe Controlled Release Drug Sales Volume Market Share by Players in 2016
Table Europe Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Europe Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Japan Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan Controlled Release Drug Sales Volume Market Share by Players in 2016
Table Japan Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Japan Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Controlled Release Drug Sales Volume Market Share by Application in 2016
Figure India Controlled Release Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Controlled Release Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India Controlled Release Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India Controlled Release Drug Sales Volume Market Share by Players (2012-2017)
Figure India Controlled Release Drug Sales Volume Market Share by Players in 2016
Table India Controlled Release Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India Controlled Release Drug Sales Volume Market Share by Type (2012-2017)
Figure India Controlled Release Drug Sales Volume Market Share by Type in 2016
Table India Controlled Release Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India Controlled Release Drug Sales Volume Market Share by Application (2012-2017)
Figure India Controlled Release Drug Sales Volume Market Share by Application in 2016
Table Allergan Basic Information List
Table Allergan Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Allergan Controlled Release Drug Sales Global Market Share (2012-2017
Figure Allergan Controlled Release Drug Revenue Global Market Share (2012-2017)
Table BioAlliance Pharma Basic Information List
Table BioAlliance Pharma Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioAlliance Pharma Controlled Release Drug Sales Growth Rate (2012-2017)
Figure BioAlliance Pharma Controlled Release Drug Sales Global Market Share (2012-2017
Figure BioAlliance Pharma Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Collegium Pharmaceutical Basic Information List
Table Collegium Pharmaceutical Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Collegium Pharmaceutical Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Collegium Pharmaceutical Controlled Release Drug Sales Global Market Share (2012-2017
Figure Collegium Pharmaceutical Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Controlled Therapeutics Basic Information List
Table Controlled Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Controlled Therapeutics Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Controlled Therapeutics Controlled Release Drug Sales Global Market Share (2012-2017
Figure Controlled Therapeutics Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Cosmo Pharmaceuticals Basic Information List
Table Cosmo Pharmaceuticals Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals Controlled Release Drug Sales Global Market Share (2012-2017
Figure Cosmo Pharmaceuticals Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Egalet Basic Information List
Table Egalet Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Egalet Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Egalet Controlled Release Drug Sales Global Market Share (2012-2017
Figure Egalet Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Encore Therapeutics Basic Information List
Table Encore Therapeutics Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Encore Therapeutics Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Encore Therapeutics Controlled Release Drug Sales Global Market Share (2012-2017
Figure Encore Therapeutics Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Flamel Technologies Basic Information List
Table Flamel Technologies Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Flamel Technologies Controlled Release Drug Sales Growth Rate (2012-2017)
Figure Flamel Technologies Controlled Release Drug Sales Global Market Share (2012-2017
Figure Flamel Technologies Controlled Release Drug Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Controlled Release Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Controlled Release Drug Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Controlled Release Drug Revenue Global Market Share (2012-2017)
Table iCeutica Basic Information List
Table iCeutica Controlled Release Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure iCeutica Controlled Release Drug Sales Growth Rate (2012-2017)
Figure iCeutica Controlled Release Drug Sales Global Market Share (2012-2017
Figure iCeutica Controlled Release Drug Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Pfizer Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Controlled Release Drug
Figure Manufacturing Process Analysis of Controlled Release Drug
Figure Controlled Release Drug Industrial Chain Analysis
Table Raw Materials Sources of Controlled Release Drug Major Players in 2016
Table Major Buyers of Controlled Release Drug
Table Distributors/Traders List
Figure Global Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Controlled Release Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Controlled Release Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Controlled Release Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Controlled Release Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global Controlled Release Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Controlled Release Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Controlled Release Drug Revenue Market Share Forecast by Regions in 2022
Figure United States Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Controlled Release Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Controlled Release Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Controlled Release Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Controlled Release Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Controlled Release Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Controlled Release Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Controlled Release Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Controlled Release Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Controlled Release Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Controlled Release Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Vegetable Capsules Sales Market Report 2017
    Published: 16-Nov-2017        Price: US 4000 Onwards        Pages: 106
    In this report, the global Vegetable Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Vegetable Capsules for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • United States Paclitaxel Market Report 2017
    Published: 16-Nov-2017        Price: US 3800 Onwards        Pages: 111
    In this report, the United States Paclitaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Pacli......
  • Global Sodium Methoxide Market Research Report 2017
    Published: 16-Nov-2017        Price: US 2900 Onwards        Pages: 117
    In this report, the global Sodium Methoxide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sodium Methoxide in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • United States Methadone Hydrochloride Market Report 2017
    Published: 16-Nov-2017        Price: US 3800 Onwards        Pages: 98
    In this report, the United States Methadone Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • Global Vegetarian Softgel Capsules Market Research Report 2017
    Published: 16-Nov-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Vegetarian Softgel Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vegetarian Softgel Capsules in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Nicotine Gum Sales Market Report 2017
    Published: 16-Nov-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Nicotine Gum market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Nicotine Gum for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Sout......
  • Global Gamma-Aminobutyric Acid Receptor Sales Market Report 2017
    Published: 16-Nov-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Gamma-Aminobutyric Acid Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Gamma-Aminobutyric Acid Receptor for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • Global Coagulation Reagent Sales Market Report 2017
    Published: 16-Nov-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Coagulation Reagent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Coagulation Reagent for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • United States Molecular Diagnostics Market Report 2017
    Published: 16-Nov-2017        Price: US 3800 Onwards        Pages: 99
    In this report, the United States Molecular Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ra......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs